Código QR (código de barras bidimensional)

HRAS is a therapeutic target in malignant chemo-resistant adenomyoepithelioma of the breast

Abstract Malignant adenomyoepithelioma (AME) of the breast is an exceptionally rare form of breast cancer, with a significant metastatic potential. Chemotherapy has been used in the management of advanced AME patients, however the majority of treatments are not effective. Recent studies report recur...

ver descrição completa

Na minha lista:
Principais autores: Ivan Bièche, Florence Coussy, Rania El-Botty, Sophie Vacher, Sophie Château-Joubert, Ahmed Dahmani, Elodie Montaudon, Cécile Reyes, David Gentien, Fabien Reyal, Francesco Ricci, André Nicolas, Caterina Marchio, Anne Vincent-Salomon, Marick Laé, Elisabetta Marangoni
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2021-09-01
coleção:Journal of Hematology & Oncology
Assuntos:
Adenomyoepithelioma
HRAS
PDX
MEK inhibitor
Acesso em linha:https://doi.org/10.1186/s13045-021-01158-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados